1-20 of 23
V Mueller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P1-07-20: Developing prognostic indicators of poor outcomes in PRAEGNANT metastatic breast cancer cohort

C Szeto, S Benz, A Nguyen, M Rübner, D Wallwiener, H Tesch, P Hadji, TN Fehm, W Janni, F Overkamp, D Lueftner, MP Lux, M Wallwiener, MW Beckmann, H Huebner, J Ettl, AD Hartkopf, V Mueller, FA Taran, E Belleville, A Schneeweiss, P Soon-Shiong, S Rabizadeh, PA Fasching
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): P1-07-20.
DOI: https://doi.org/10.1158/1538-7445.SABCS17-P1-07-20
Published: 15 February 2018
View article
Journal Articles

Abstract P3-11-07: Factors associated with first line chemotherapy use in patients with hormone receptor positive, HER2 negative metastatic breast cancer – data from the PRAEGNANT breast cancer registry

J Huober, PA Fasching, F-A Taran, B Volz, F Overkamp, HC Kolberg, P Hadji, H Tesch, L Haeberle, J Ettl, AD Hartkopf, MP Lux, D Lueftner, M Wallwiener, V Mueller, MW Beckmann, E Belleville, P Wimberger, C Hielscher, M Geberth, N Fersis, W Abenhardt, C Kurbacher, R Wuerstlein, C Thomssen, M Untch, W Janni, D Wallwiener, SY Brucker, A Schneeweiss, TN Fehm
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): P3-11-07.
DOI: https://doi.org/10.1158/1538-7445.SABCS17-P3-11-07
Published: 15 February 2018
View article
Journal Articles

Abstract PD1-02: Cancer predisposition genes in metastatic breast cancer – Association with metastatic pattern, prognosis, patient and tumor characteristics

PA Fasching, C Hu, SN Hart, EC Polley, KY Lee, RD Gnanolivu, J Lilyquist, AD Hartkopf, FA Taran, W Janni, P Hadji, H Tesch, L Haeberle, J Ettl, MP Lux, D Lueftner, M Wallwiener, V Mueller, MW Beckmann, E Belleville, P Wimberger, M Untch, H-C Kolberg, TN Fehm, F Overkamp, D Wallwiener, SY Brucker, A Schneeweiss, F Couch
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): PD1-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS17-PD1-02
Published: 15 February 2018
View article
Journal Articles

Abstract OT3-05-04: A randomized, open-label, multi-center phase IV study evaluating palbociclib plus endocrine treatment versus a chemotherapy-based treatment strategy in patients with hormone receptor-positive, HER2-negative metastatic breast cancer in a real world setting (PADMA)

S Loibl, J Barinoff, S Seiler, T Decker, C Denkert, A-C Hardy-Bessard, E Senkus-Konefka, F Cognetti, C Palmieri, K Gelmon, K Luebbe, J Furlanetto, V Mueller, C Mundhenke, M Schmidt, G von Minckwitz, M Uhlig, N Burchardi, M Thill
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): OT3-05-04.
DOI: https://doi.org/10.1158/1538-7445.SABCS17-OT3-05-04
Published: 15 February 2018
View article
Journal Articles

Abstract P6-11-10: Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry

M Wallwiener, N Nabieva, L Haeberle, FA Taran, AD Hartkopf, B Volz, F Overkamp, AL Brandl, H-C Kolberg, P Hadji, H Tesch, J Ettl, MP Lux, D Lueftner, E Belleville, PA Fasching, W Janni, MW Beckmann, P Wimberger, C Hielscher, T Fehm, SY Brucker, D Wallwiener, A Schneeweiss, V Mueller
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): P6-11-10.
DOI: https://doi.org/10.1158/1538-7445.SABCS17-P6-11-10
Published: 15 February 2018
View article
Journal Articles

Abstract OT1-03-05: The DETECT V-Study – Comparison of dual HER2-targeted therapy with trastuzumab plus pertuzumab in combination with chemo- or endocrine therapy in addition with CDK4/6 inhibition in patients with HER2-positive and hormone-receptor positive metastatic breast cancer

T Romashova, A Polasik, TWP Friedl, B Rack, M Tzschaschel, PA Fasching, F-A Taran, A Hartkopf, A Schneeweiss, V Mueller, A Bahriye, K Pantel, F Meier-Stiegen, P Wimberger, W Janni, T Fehm, J Huober
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): OT1-03-05.
DOI: https://doi.org/10.1158/1538-7445.SABCS17-OT1-03-05
Published: 15 February 2018
View article
Journal Articles

Abstract S3-01: IMENEO: International MEta-analysis of circulating tumor cell detection in early breast cancer patients treated by NEOadjuvant chemotherapy

F-C Bidard, S Michiels, V Mueller, S Riethdorf, LJ Esserman, A Lucci, B Naume, J Horiguchi, R Gisbert-Criado, S Sleijfer, M Toi, JA Garcia-Saenz, A Hartkopf, D Generali, F Rothe, J Smerage, L Muinelo, J Stebbing, P Viens, M Magbanua, CS Hall, O Engebråtenm, D Takata, J Vidal-Martínez, W Onstenk, N Fujisawa, E Diaz-Rubio, F-A Taran, MR Cappelletti, M Ignatiadis, N Name, C Proudhon, D Wolf, J Bowman Bauldry, E Borgen, R Nagaoka, V Carañana, J Kraan, M Maestro, SY Brucker, K Weber, F Reyal, D Amara, M Gopalkrishna Karhade, R Ruud Mathiesen, H Tokiniwa, A Llombart-Cussac, K D'Hollander, P Cottu, JW Park, S Loibl, J-Y Pierga, K Pantel
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): S3-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS16-S3-01
Published: 15 February 2017
View article
Journal Articles

Abstract P1-01-03: Dynamics of circulating tumor cells during the course of chemotherapy and prognostic relevance across molecular subtypes in high-risk early breast cancer patients – Results from the adjuvant SUCCESS A trial

MLJ Tzschaschel, B Rack, U Andergassen, TWP Friedl, A Schneeweiss, V Mueller, F Tanja, K Pantel, J Gade, R Lorenz, M Rezai, H Tesch, U Soeling, A Polasik, M Alunni-Fabbroni, EK Trapp, S Mahner, C Schindlbeck, W Lichtenegger, MW Beckmann, PA Fasching, W Janni
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): P1-01-03.
DOI: https://doi.org/10.1158/1538-7445.SABCS16-P1-01-03
Published: 15 February 2017
View article
Journal Articles

Abstract P6-13-02: Efficacy of first-line bevacizumab (BEV)-containing therapy for poor-prognosis advanced breast cancer (aBC): Subgroup analyses of the German AVANTI observational study

V Mueller, A Jakob, B Aktas, D Pott, A Grafe, P Jungberg, W Maerz, W Fett, H-R Bruch, P Klare, E Boller, S Hoefflin, A Schneeweiss
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): P6-13-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS16-P6-13-02
Published: 15 February 2017
View article
Journal Articles

Abstract S2-03: Persistence of circulating tumor cells in high risk early breast cancer patients during follow-up care suggests poor prognosis – Results from the adjuvant SUCCESS A trial

W Janni, B Rack, P Fasching, L Haeberle, T Friedl, H Tesch, R Lorenz, J Neugebauer, J Koch, B Jaeger, T Fehm, V Mueller, A Schneeweiß, W Lichtenegger, M Beckmann, C Scholz, K Pantel, E Trapp
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): S2-03.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-S2-03
Published: 15 February 2016
View article
Journal Articles

Abstract P6-17-08: Brain metastases in breast cancer network Germany (BMBC, GBG 79): First analysis of 548 patients from the multicenter registry

I Witzel, S Loibl, E Laakmann, D Augustin, F Flock, H-H Dohmen, G Durmus, M Frank, T Hesse, A Ignatov, T Kühn, T Neunhöffer, T-W Park-Simon, M Schmidt, A Stefek, R Weide, F Würschmidt, T Fehm, V Moebus, G von Minckwitz, N Burchardi, V Mueller
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): P6-17-08.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-P6-17-08
Published: 15 February 2016
View article
Journal Articles

Abstract OT3-02-09: Seraphina – Safety efficacy and patient reported outcomes of advanced breast cancer patients: Therapy management with NAB-paclitaxel in daily routine

PA Fasching, M Wallwiener, MP Lux, V Mueller, A Schneeweiss, H Tesch, SY Brucker, L Haeberle, T Spall, E Belleville, H-J Lück
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): OT3-02-09.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-OT3-02-09
Published: 15 February 2016
View article
Journal Articles

Abstract PD6-3: Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients

B Aktas, S Kasimir-Bauer, V Mueller, B Rack, W Janni, K Pantel, T Fehm, M Tewes
Journal: Cancer Research
Cancer Res (2013) 73 (24_Supplement): PD6-3.
DOI: https://doi.org/10.1158/0008-5472.SABCS13-PD6-3
Published: 15 December 2013
View article
Journal Articles

Abstract OT1-1-10: DETECT III - A multicenter, randomized, phase III study to compare standard therapy alone versus standard therapy plus lapatinib in patients with initially HER2-negative metastatic breast cancer but with HER2-positive circulating tumorcells

CA Melcher, JW Janni, A Schneeweiss, PA Fasching, CD Hagenbeck, B Aktas, K Pantel, EF Solomayer, U Ortmann, BAS Jaeger, V Mueller, BK Rack, TN Fehm
Journal: Cancer Research
Cancer Res (2012) 72 (24_Supplement): OT1-1-10.
DOI: https://doi.org/10.1158/0008-5472.SABCS12-OT1-1-10
Published: 15 December 2012
View article
Journal Articles

P3-01-12: Prognostic Impact of RANK, RANKL and OPG Gene Expression in ER Positive Primary Breast Cancer.

E Ruckhaeberle, V Mueller, M Schmidt, N Saenger, L Hanker, R Gaetje, A Ahr, U Holtrich, T Karn, A Rody, M Kaufmann
Journal: Cancer Research
Cancer Res (2011) 71 (24_Supplement): P3-01-12.
DOI: https://doi.org/10.1158/0008-5472.SABCS11-P3-01-12
Published: 15 December 2011
View article
Journal Articles

P4-07-13: Prognostic Impact of Circulating Tumor Cells Assessed with the Cell Search Assay and Adna Test Breast in Metastatic Breast Cancer Patients – The DETECT Study.

V Mueller, S Riethdorf, B Rack, J Wolfgang, PA Fasching, E Solomayer, B Aktas, S Kasimir-Bauer, D Mury, K Pantel, T Fehm
Journal: Cancer Research
Cancer Res (2011) 71 (24_Supplement): P4-07-13.
DOI: https://doi.org/10.1158/0008-5472.SABCS11-P4-07-13
Published: 15 December 2011
View article
Journal Articles

Abstract P3-14-19: Long-Time Tumor Remissions under Trastuzumab Therapy in HER2- Positive Locally Recurrent or Metastatic Breast Cancer: First Interim Analysis of the HER-OS Database

F Jaenicke, V Mueller, W Abenhardt, M Kaufmann, W Schoenegg, A. Schneeweiss
Journal: Cancer Research
Cancer Res (2010) 70 (24_Supplement): P3-14-19.
DOI: https://doi.org/10.1158/0008-5472.SABCS10-P3-14-19
Published: 15 December 2010
View article
Journal Articles

Abstract PD04-06: Changes in Circulating Tumor and Endothelial Cells in Peripheral Blood of Patients Treated in the Neoadjuvant Chemotherapy Plus Targeted Treatment Breast Cancer Study “GeparQuinto”

S Riethdorf, V Mueller, O Mauermann, T Rau, S Loibl, H Eidtmann, C Solbach, H Tesch, I Schrader, K Kittel, T Fehm, F Holms, M Untch, G von Minckwitz, K. Pantel
Journal: Cancer Research
Cancer Res (2010) 70 (24_Supplement): PD04-06.
DOI: https://doi.org/10.1158/0008-5472.SABCS10-PD04-06
Published: 15 December 2010
View article
Journal Articles

Prospective Evaluation of Serum HER2 and HER2 Expression on Circulating Tumor Cells in Patients with Metastatic Breast Cancer within the DETECT Study.

V. Mueller, S. Riethdorf, B. Rack, W. Janni, P. Fasching, K. Pantel, G. Gebauser, E. Solomayer, B. Aktas, S. Kasemier-Bauer, T. Fehm
Journal: Cancer Research
Cancer Res (2009) 69 (24_Supplement): 3050.
DOI: https://doi.org/10.1158/0008-5472.SABCS-09-3050
Published: 15 December 2009
View article
Journal Articles

The Luminal B Marker NHERF1 Predicts Endocrine Resistance.

A. Rody, T. Karn, C. Solbach, E. Ruckhaeberle, L. Hanker, V. Mueller, M. Schmidt, R. Gaetje, U. Holtrich, M. Kaufmann
Journal: Cancer Research
Cancer Res (2009) 69 (24_Supplement): 3164.
DOI: https://doi.org/10.1158/0008-5472.SABCS-09-3164
Published: 15 December 2009
View article